CREST Pathway Company pentest delivery through CyberImmune: what buyers should know

Assurance wording matters in security. Buyers should distinguish between a product platform, the company that delivers an engagement, and the methodology used for testing. Those are related signals, but they are not the same claim.

DeepScan is a CyberImmune company and continuous pentesting platform. DeepScan expert-led pentests are delivered through CyberImmune, a CREST Pathway Company. That wording is intentional and precise.

Why does this matter? Auditors, procurement teams, and enterprise security reviewers may ask whether a pentest was performed by qualified professionals, whether methodology followed recognized standards, and whether the report is acceptable evidence. Precise wording builds trust.

When evaluating any provider, ask who performs the work, what methodology is used, who reviews the report, whether retesting is included, and how evidence is protected. A logo alone is not a substitute for engagement details.

AI-powered platforms add another dimension. Automation can accelerate discovery, validation, and reporting, but the final assurance story still depends on scope, controls, operator review, and report quality. The right model combines platform speed with qualified human oversight.

For DeepScan customers, the practical takeaway is simple: use self-serve workflows when you need fast validation and proof, and use expert-led delivery through CyberImmune, a CREST Pathway Company, when your auditor or buyer requires a formal pentest engagement.

Clear delivery language is part of producing evidence that security buyers can trust.